vs
Side-by-side financial comparison of TPG Mortgage Investment Trust, Inc. (MITT) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
TPG Mortgage Investment Trust, Inc. is the larger business by last-quarter revenue ($20.4M vs $18.3M, roughly 1.1× ROCKWELL MEDICAL, INC.). TPG Mortgage Investment Trust, Inc. runs the higher net margin — 65.0% vs -3.0%, a 68.0% gap on every dollar of revenue. On growth, TPG Mortgage Investment Trust, Inc. posted the faster year-over-year revenue change (17.7% vs -25.6%). Over the past eight quarters, TPG Mortgage Investment Trust, Inc.'s revenue compounded faster (9.1% CAGR vs -10.1%).
TPG Mortgage Investment Trust, Inc. is a real estate investment trust managed by global alternative asset firm TPG. It primarily invests in residential and commercial mortgage-backed securities, performing and non-performing mortgage loans, and other credit-linked real estate assets, with its core market being the United States. It generates returns via net interest income from holdings and strategic asset disposition gains.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
MITT vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.4M | $18.3M |
| Net Profit | $13.3M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 67.1% | -2.2% |
| Net Margin | 65.0% | -3.0% |
| Revenue YoY | 17.7% | -25.6% |
| Net Profit YoY | -7.0% | 26.7% |
| EPS (diluted) | $0.27 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.4M | $18.3M | ||
| Q3 25 | $19.5M | $15.9M | ||
| Q2 25 | $17.8M | $16.1M | ||
| Q1 25 | $18.8M | $18.9M | ||
| Q4 24 | $17.4M | $24.7M | ||
| Q3 24 | $14.9M | $28.3M | ||
| Q2 24 | $16.4M | $25.8M | ||
| Q1 24 | $17.2M | $22.7M |
| Q4 25 | $13.3M | $-554.0K | ||
| Q3 25 | $20.0M | $-1.8M | ||
| Q2 25 | $3.9M | $-1.5M | ||
| Q1 25 | $11.5M | $-1.5M | ||
| Q4 24 | $14.3M | $-756.0K | ||
| Q3 24 | $16.6M | $1.7M | ||
| Q2 24 | $3.9M | $343.0K | ||
| Q1 24 | $20.9M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 67.1% | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | 20.9% | -8.4% | ||
| Q1 25 | 54.6% | -7.2% | ||
| Q4 24 | 76.7% | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | 18.4% | 2.0% | ||
| Q1 24 | — | -5.8% |
| Q4 25 | 65.0% | -3.0% | ||
| Q3 25 | 102.5% | -11.0% | ||
| Q2 25 | 22.2% | -9.3% | ||
| Q1 25 | 60.9% | -8.0% | ||
| Q4 24 | 82.2% | -3.1% | ||
| Q3 24 | 111.3% | 5.9% | ||
| Q2 24 | 24.0% | 1.3% | ||
| Q1 24 | 121.6% | -7.6% |
| Q4 25 | $0.27 | $-0.01 | ||
| Q3 25 | $0.47 | $-0.05 | ||
| Q2 25 | $-0.05 | $-0.05 | ||
| Q1 25 | $0.21 | $-0.04 | ||
| Q4 24 | $0.30 | $-0.02 | ||
| Q3 24 | $0.40 | $0.04 | ||
| Q2 24 | $-0.02 | $0.01 | ||
| Q1 24 | $0.55 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.8M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $560.7M | $37.0M |
| Total Assets | $8.7B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.8M | $10.7M | ||
| Q3 25 | $59.0M | $13.6M | ||
| Q2 25 | $88.7M | $12.5M | ||
| Q1 25 | $115.5M | $11.4M | ||
| Q4 24 | $118.7M | $15.7M | ||
| Q3 24 | $102.5M | $12.3M | ||
| Q2 24 | $120.9M | $11.9M | ||
| Q1 24 | $100.3M | $6.6M |
| Q4 25 | $560.7M | $37.0M | ||
| Q3 25 | $559.8M | $37.0M | ||
| Q2 25 | $536.4M | $30.4M | ||
| Q1 25 | $543.9M | $31.5M | ||
| Q4 24 | $543.4M | $32.6M | ||
| Q3 24 | $540.1M | $29.1M | ||
| Q2 24 | $533.5M | $23.5M | ||
| Q1 24 | $539.6M | $20.6M |
| Q4 25 | $8.7B | $57.1M | ||
| Q3 25 | $9.0B | $57.5M | ||
| Q2 25 | $7.5B | $52.6M | ||
| Q1 25 | $7.3B | $54.0M | ||
| Q4 24 | $6.9B | $59.2M | ||
| Q3 24 | $7.0B | $57.1M | ||
| Q2 24 | $7.1B | $53.0M | ||
| Q1 24 | $6.4B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $59.6M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | 4.48× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $59.6M | $2.3M | ||
| Q3 25 | $17.4M | $-1.3M | ||
| Q2 25 | $11.5M | $1.8M | ||
| Q1 25 | $12.0M | $-3.5M | ||
| Q4 24 | $55.8M | $865.0K | ||
| Q3 24 | $14.5M | $4.3M | ||
| Q2 24 | $13.7M | $1.4M | ||
| Q1 24 | $12.0M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 4.48× | — | ||
| Q3 25 | 0.87× | — | ||
| Q2 25 | 2.92× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 3.91× | — | ||
| Q3 24 | 0.87× | 2.57× | ||
| Q2 24 | 3.50× | 4.20× | ||
| Q1 24 | 0.57× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MITT
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
